Fig. 6: BSA-based encapsulation of JOC1 increases free-compound solubility and efficacy.
From: Characterization of a new small-molecule inhibitor of HDAC6 in glioblastoma
a Representation and b values of encapsulation yields and size of BSANP@JOC1 at pH 7.4 and 11.5; c Size distribution of synthesized BSANP@JOC1, at pH 11.5 and 1 mg/ml JOC1; d Cell viability of U87-MG cells after 72 h of control, free JOC1 and BSANP@JOC1 treatment (n = 3).
